Sign in
4/A

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0000899243-20-004524

Chairman acquired 60,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

El-Hibri Fuad · Chairman

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-05 Exercise or conversion : show line 1 in the form +20,000 $25.62 $512,400 1,499,018 D
2020-02-05 Exercise or conversion : show line 2 in the form +20,000 $25.62 $512,400 1,519,018 D
2020-02-05 Exercise or conversion : show line 3 in the form +8,316 $25.62 $213,056 1,479,018 D
2020-02-06 Exercise or conversion : show line 4 in the form +11,684 $25.62 $299,344 1,479,018 D

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2020-02-05 Exercise or conversion : show line 5 in the form Employee Stock Options (Right to Buy) −20,000 103,318 D
2020-02-05 Exercise or conversion : show line 6 in the form Employee Stock Options (Right to Buy) −20,000 83,318 D
2020-02-05 Exercise or conversion : show line 7 in the form Employee Stock Options (Right to Buy) −8,316 75,002 D
2020-02-06 Exercise or conversion : show line 8 in the form Employee Stock Options (Right to Buy) −11,684 63,318 D
Loading xslF345X03/doc4a.xml…